Displaying One Session

View
Oviedo Auditorium (CC5)

Bayer - What potential do TKIs have to optimize outcomes in refractory mCRC and uHCC?

Date
27.09.2019
Time
18:00 - 20:00
Chairs
  • Eric Van Cutsem (Leuven, Belgium)
Bayer - What potential do TKIs have to optimize outcomes in refractory mCRC and uHCC? Industry Satellite Symposium

Introduction: TKI evolution in GI cancers (ID 6576)

Lecture Time
18:00 - 18:05
Speakers
  • Eric Van Cutsem (Leuven, Belgium)
Session Name
Bayer - What potential do TKIs have to optimize outcomes in refractory mCRC and uHCC?
Location
Oviedo Auditorium (CC5), Fira Gran Via, Barcelona, Spain
Date
27.09.2019
Time
18:00 - 20:00
Bayer - What potential do TKIs have to optimize outcomes in refractory mCRC and uHCC? Industry Satellite Symposium

What is the role for TKIs in the era of immunotherapy in GI cancers? (ID 6577)

Lecture Time
18:05 - 18:25
Speakers
  • Heinz Josef Lenz (Los Angeles, CA, United States of America)
Session Name
Bayer - What potential do TKIs have to optimize outcomes in refractory mCRC and uHCC?
Location
Oviedo Auditorium (CC5), Fira Gran Via, Barcelona, Spain
Date
27.09.2019
Time
18:00 - 20:00
Bayer - What potential do TKIs have to optimize outcomes in refractory mCRC and uHCC? Industry Satellite Symposium

How can we optimize outcomes for refractory mCRC patients with TKIs? An interactive case study panel discussion (ID 6578)

Lecture Time
18:25 - 19:25
Speakers
  • Axel Grothey (Germantown, TN, United States of America)
  • Tanios Bekaii-Saab (Phoenix, United States of America)
  • Guillem Argiles Martinez (Barcelona, Spain)
  • Michel P. Ducreux (Villejuif, CEDEX, France)
Session Name
Bayer - What potential do TKIs have to optimize outcomes in refractory mCRC and uHCC?
Location
Oviedo Auditorium (CC5), Fira Gran Via, Barcelona, Spain
Date
27.09.2019
Time
18:00 - 20:00
Bayer - What potential do TKIs have to optimize outcomes in refractory mCRC and uHCC? Industry Satellite Symposium

How do we navigate the HCC treatment landscape? (ID 6583)

Lecture Time
19:25 - 19:45
Speakers
  • Chris Verslype (Leuven, Belgium)
Session Name
Bayer - What potential do TKIs have to optimize outcomes in refractory mCRC and uHCC?
Location
Oviedo Auditorium (CC5), Fira Gran Via, Barcelona, Spain
Date
27.09.2019
Time
18:00 - 20:00
Bayer - What potential do TKIs have to optimize outcomes in refractory mCRC and uHCC? Industry Satellite Symposium

Panel Q&A: Select your most pressing question for an expert panel discussion (ID 6584)

Lecture Time
19:45 - 19:55
Session Name
Bayer - What potential do TKIs have to optimize outcomes in refractory mCRC and uHCC?
Location
Oviedo Auditorium (CC5), Fira Gran Via, Barcelona, Spain
Date
27.09.2019
Time
18:00 - 20:00
Bayer - What potential do TKIs have to optimize outcomes in refractory mCRC and uHCC? Industry Satellite Symposium

Summary and closing (ID 7300)

Lecture Time
19:55 - 20:00
Speakers
  • Eric Van Cutsem (Leuven, Belgium)
Session Name
Bayer - What potential do TKIs have to optimize outcomes in refractory mCRC and uHCC?
Location
Oviedo Auditorium (CC5), Fira Gran Via, Barcelona, Spain
Date
27.09.2019
Time
18:00 - 20:00